You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Tamsulosin, a competitive α adrenoceptor antagonist has an affinity for which of the following receptors and explain in detail?
The actions of the α1-adrenoceptor antagonist tamsulosin have been examined at functional α1-adrenoceptor subtypes and compared with those at the human prostate receptor.
At the α1D-adrenoceptors of the rat aorta, tamsulosin acted as a competitive antagonist with a high affinity (pKB=10.1).
At the α1B-adrenoceptor of the rat spleen and rabbit corpus cavernosum penis, tamsulosin again acted as a competitive antagonist but with a significantly lower affinity (pKB=8.9–9.2).
Tamsulosin acted as an insurmountable antagonist of the α1A-adrenoceptor-mediated responses of the rat and human vas deferens, reducing maximal responses to phenylephrine by 20% and 50%, respectively, at an antagonist concentration of 1 nm. Responses of depolarized (100 mm KCl) rat vas deferens preparations were unaffected by 10 nm tamsulosin but this concentration reduced maximal responses to 5-hydroxytryptamine (5-HT) in this tissue.
When longer antagonist incubation periods (⩾60 min) were used, tamsulosin behaved as a competitive antagonist on the human prostate with a significantly higher affinity (pKB=10.0) than obtained at the α1B-adrenoceptor.
The data demonstrate that tamsulosin is a high-affinity antagonist at functional α1-adrenoceptors with a selectivity α1D⩾α1A>α1B. In some tissues, the compound exhibits an additional unsurmountable antagonist action, the clinical significance of which is unknown.